Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Market Commentary — 7956 total
Analysts sent mixed signals on Friday, with W.W. Grainger winning a consensus upgrade while Paychex saw its average target price cut. Grainger's upgrade lifted the industrial distributor's consensus rating. The $60bn…
Bill Gates filed purchases of RSG worth $241 million in early September. The filings, submitted between September 1 and 3, covered 15 separate trades between August 28 and September 2. Gates bought shares at prices…
Short sellers made bold new bets this week. The moves span healthcare, aerospace, and consumer names — with some eye-popping jumps in just seven days. MMED (MiniMed Group) saw the biggest mainstream surge. Short…
Fixed income pulled in $16.3B in the past week. That stands out against a $17B net equity outflow. The contrast is stark. Over three months, both asset classes attracted money — but this week's tilt toward bonds marks…
Q3 results season is under way. Micron Technology is the week's most-watched name. The memory chip maker reports Q4 2026 results Wednesday after the close. Micron is up 279% year-to-date. Both bulls and bears are…
Q3 results season kicks off this week. Options markets are reacting — with chips and beaten-down consumer names drawing the heaviest flow. Micron Technology leads both the bullish and bearish bets tables among large…
The earnings calendar heats up this week. Several high-profile names report across tech, consumer, and finance. Today and tomorrow bring the first wave. IDT kicks off Monday with its Q4 2026 call. Vail Resorts and…
DRI drew the most analyst attention this session. Three brokers moved their targets after the restaurant group's latest results. Mizuho and Freedom Capital Markets both raised targets. Mizuho went to $245 from $235.…
NVIDIA director Mark Stevens filed to sell over $410M worth of shares in early September — the largest single-insider disclosure period in the data. Stevens offloaded 1.85 million shares across seven transactions…
Short sellers made bold moves this week. Data from ORTEX as of September 24 shows dramatic swings in short positioning across multiple names. Biggest new short target: BRVE (Braveheart Bio) saw its short interest…
Quarter-end positioning is reshaping short interest fast. GME saw its SI % of FF jump from 0.9% to 7.5% in one week. Bears are rebuilding bearish bets on the meme stock favourite. SPCX also drew fresh shorts, with SI %…
As Q3 winds down, options markets are flashing signals across several high-profile names. Semiconductor stocks and beaten-down consumer plays dominate flow. MU leads in negative options bets over the past week. The…
The final days of Q3 2026 bring a cluster of high-profile earnings. Markets will be watching closely across consumer, tech, and leisure sectors. Today and Tomorrow IDT kicks off Monday with its Q4 2026 earnings call.…
Analyst desks were busy Saturday. Three firms moved their targets on DRI after the restaurant group's latest results, but they couldn't agree on direction. Mizuho's Nick Setyan raised his target to $245 from $235,…
An NVIDIA board director quietly filed over $411 million in stock sales in early September. Mark A. Stevens, an Independent Director, sold nearly 1.85 million shares between August 31 and September 2. The filings hit…
Short interest data as of September 24 shows a dramatic week for bearish positioning. The biggest mover is BRVE (Braveheart Bio). Its SI % of FF exploded to 585.6%, up from 226.5% just seven days earlier — a 359-point…
The biggest story this week is a sharp reversal in US equity flows. US-focused ETFs shed a net $30.8B in the past week. Over three months, the same funds pulled in $147.5B. That gap is striking. Fixed income is the…
The sharpest tension today sits in biotech. NTLA (Intellia Therapeutics) is up 31% year-to-date and options traders are turning bullish. Yet short sellers are not budging — the stock carries a short score of 77 and…
Options traders are turning bullish on NTLA even as short sellers hold firm. Intellia Therapeutics carries a short score of 77 and days-to-cover of 6.8. That sets up a sharp divergence — puts versus calls, bears versus…
Earnings season kicks into gear with high-profile reports across tech, consumer, and finance. Monday and Today — IDT holds its Q4 2026 earnings call today. Vail Resorts reports Q4 results this afternoon. Jefferies…
